Portfolio – Sep 18, 2024 Almer Technologies secures 3 million USD in new funding round, led by Vi Partners Read More
Portfolio – Aug 22, 2024 FLOWIT AG Successfully Closes Oversubscribed First Funding Round: 4 MM CHF Read More
Portfolio – Jul 25, 2024 Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix Read More
Insights & Thoughts – May 29, 2024 How Sibylla Biotech is Using AI to Solve the Problem of Non-Druggable Targets Read More
Portfolio – May 13, 2024 A coffee chat with Vincent Bieri, co-founder of Nexthink – Switzerland's fastest-growing SaaS unicorn Read More
Insights & Thoughts – Apr 25, 2024 Navigating your tech career, a Venture Capitalist’s perspective Read More
Insights & Thoughts – Mar 19, 2024 Exploring AI Agents: The Evolution from Chatbots to Intelligent Autonomous Systems Read More
Portfolio – Feb 12, 2024 The most convenient & smart way to lease any car, anywhere - Why we invested in LeaseTeq Read More
Portfolio – Dec 21, 2023 Vi Partners announce a new CHF 8 Mio. Series A investment in LeaseTeq Read More
Portfolio – Dec 19, 2023 Study Published in Nature Digital Medicine Shows Potential Predictive Power of Augmented Reality-based Cognitive and Functional Assessment for Alzheimer’s Disease Read More
Portfolio – Dec 19, 2023 Top Swiss Banks Embrace GenAI Transformation with Unique FinanceGPT Read More
Portfolio – Nov 08, 2023 Araris Biotech AG Announces Research Collaboration with Taiho Pharmaceutical to Develop Next-Generation ADCs Using Araris’ Proprietary Linker-Conjugation Technology Read More
Portfolio – Oct 24, 2023 JenaValve Announces Late-Breaking Data From the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints Read More
Insights & Thoughts – Sep 27, 2023 Unlocking Startup Potential: The Vi Partners 4Ps Blueprint Read More
Portfolio – Aug 14, 2023 Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing Read More
Portfolio – Aug 09, 2023 Oculis announce positive results from a Phase 3 OPTIMIZE trial showing that a daily does of OCS-01 eye drops treats inflammation and pain following cataract surgery Read More
Insights & Thoughts – Jul 11, 2023 Empowering Breast Cancer Screening Globally - Why we invested in Vara Read More
Insights & Thoughts – Jun 19, 2023 Building the digital healthcare enterprise ecosystem – customer by customer Read More
Portfolio – May 22, 2023 Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops Read More
Portfolio – Apr 19, 2023 Manuel Grenacher, CEO of Unique, shares his views on getting comfortable being uncomfortable and the power of company culture. Read More
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)